# FDA Warning Letter: Hubei Kangzheng Pharmaceutical Co., Ltd.
> 2022-01-11 · Center for Drug Evaluation and Research | CDER · `bde946ece77702ad`
## Letter
- **Company:** Hubei Kangzheng Pharmaceutical Co., Ltd.
- **Posted Date:** 2022-01-11
- **Letter Issue Date:** 2021-11-23
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*